Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
QCOR: Stock Quote & Summary Data
2.72%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 8.75 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 674,028 |
| Previous Close | $ 4.05 |
| 52 Wk High / Low | $ 9.81 / $ 3.10 |
| Shares Outstanding | 64,097,000 |
| Market Value | $ 266,643,520 |
| P/E Ratio | 7.3 |
| Forward P/E (1yr) | 9.42 |
| Earnings Per Share | $ 0.57 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 1.26 |
| NASDAQ Official Open Price: | $ 4.03 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 4.16 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About QCOR?
Ask your question about about Questcor Pharmaceuticals, Inc. (QCOR) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
This Annual Report contains forward-looking statements that have been made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “forecasts,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Item 1 “Business,” Item 1A “Risk Factors,” and Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as those discussed in any documents incorporated by reference herein or therein. ... More ...
Links to all Questcor Pharmaceuticals, Inc. (QCOR) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for QCOR |
||
|
Playboy, Helicos: Early Volume Plays - TheStreet 11/17/2009 9:03AM |
||
|
Questcor Announces Third Quarter 2009 Results - GlobeNewswire 11/02/2009 4:05PM |
||
|
Questcor Pharma Q3 09 Earnings Conference Call At 4:30 PM - RTT News 11/02/2009 1:59PM |
||
|
Child Neurology Foundation Announces $30,000 Grant for Research Into Cause and Treatment of Infantile Spasms - PR Newswire 10/28/2009 10:00AM |
||
|
Questcor to Present at the 20th Annual Oppenheimer Healthcare Conference in New York - GlobeNewswire 10/27/2009 6:30AM |
||
|
Questcor Issues Corrected Dial-in Numbers for November 2nd Quarterly Conference Call - GlobeNewswire 10/26/2009 12:15PM |
||
|
Questcor Announces Third Quarter 2009 Earnings Release Date and Conference Call - GlobeNewswire 10/23/2009 6:30AM |
